We determined the expression of E-cadherin, α-, β- and γ-catenin in human breast carcinomas using real time quantitative polymerase chain reaction and investigated whether the expression levels are associated with known tumour variables or patient survival. This evidence concerns the gene CDH1 and breast carcinoma.